Maple Cross Remedies Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2001.
2001 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Maple Cross Remedies Private Limited

Maple Cross Remedies Private Limited, a active private limited company, was established on 12 June 2001 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85199MH2001PTC132312. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Jaikishan Mangharam Shahani (Director), Mahesh Rochaldas Bakhru (Director), Anuj Jaikishen Shahani (Director). Past directors included Jaikishan Mangharam Shahani, Anuj Jaikishen Shahani, Usha Shahani. It holds ₹1.57 Cr open charges and ₹3.26 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at F-714 Autumn Grove Chs Ltd., Akurli Road, Near Lokhandwala Foundation School, Kand, Ivali (E), Mumbai, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85199MH2001PTC132312

  • Registration Number

    132312

  • Incorporation Date

    12 June 2001

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 24 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.57 Cr
  • Satisfied Charges ₹ 3.26 Cr
  • Revenue Growth **** -0.05%
  • Profit Growth **** 4.54%
  • Ebitda **** 50.42%
  • Net Worth 17.62%
  • Total Assets -0.18%
Company report

Maple Cross Remedies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Maple Cross Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Maple Cross Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Jaikishan Mangharam Shahani Director 12 Jun 2001 Current
Mahesh Rochaldas Bakhru Director 12 Jun 2001 Current
Anuj Jaikishen Shahani Director 16 Aug 2005 Current
Usha Shahani Director 26 May 2015 Current
Deepika Shahani Director 26 May 2015 Current
Roma Mahesh Bakhru Director 26 May 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 02 Mar 2022 Past
Pramod Abcsdd Director 02 Mar 2022 Past
Pramod Abcsdd Director 02 Mar 2022 Past
Pramod Abcsdd Director 02 Mar 2022 Past
Pramod Abcsdd Director 02 Mar 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maple Cross Remedies.

Maple Cross Remedies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.05% decrease. The company also saw a slight improvement in profitability, with a 4.54% increase in profit. The company's net worth Soared by an impressive increase of 17.62%.

Maple Cross Remedies revenue growth over time
Maple Cross Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -0.05%
*******
*******
*******
*******
Revenue from Operations
*******
 0.16%
*******
*******
*******
*******
Total Assets
*******
 -0.18%
*******
*******
*******
*******
Profit or Loss
*******
 4.54%
*******
*******
*******
*******
Net Worth
*******
 17.62%
*******
*******
*******
*******
EBITDA
*******
 50.42%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maple Cross Remedies?

Unlock access to Maple Cross Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹15,679,000.00

Satisfied Charges

₹32,580,000.00

Charges Breakdown by Lending Institutions
  • Others : 1.01 Cr
  • Hdfc Bank Limited : 0.41 Cr
  • Corporation Bank : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
02 Mar 2024 Hdfc Bank Limited ₹2.58 M Open
03 Mar 2022 Hdfc Bank Limited ₹1.50 M Open
30 Jun 2021 Others ₹1.01 Cr Open
12 Jan 2005 Corporation Bank ₹1.50 M Open
12 May 2021 Others ₹2.70 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Maple Cross Remedies?

Unlock and access historical data on people associated with Maple Cross Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maple Cross Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Cross Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maple Cross Remedies
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Maple Cross Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Maple Cross Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.58 M with Charge ID 100892934 was registered on 02 Mar 2024. was recorded as a recent event.

  • Charges

    The activity A charge registered on 24 May 2017 via Charge ID 100127537 with Hdfc Bank Limited was fully satisfied on 25 Jul 2022. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.50 M with Charge ID 100552411 was registered on 03 Mar 2022. was recorded as a recent event.

  • Charges

    A charge registered on 12 May 2021 via Charge ID 100445465 with Others was fully satisfied on 24 Sep 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maple Cross Remedies Private Limited?

The CIN of Maple Cross Remedies Private Limited is U85199MH2001PTC132312.

Where is Maple Cross Remedies Private Limited headquartered?

Maple Cross Remedies Private Limited is headquartered at F-714 Autumn Grove Chs Ltd., Akurli Road, Near Lokhandwala Foundation School, Kand, Ivali (E), Mumbai, Maharashtra, 400101.

When was Maple Cross Remedies Private Limited incorporated?

Maple Cross Remedies Private Limited was incorporated on 12 June 2001.

Who are the current directors of Maple Cross Remedies Private Limited?

The current directors of Maple Cross Remedies Private Limited are

What is the primary industry of Maple Cross Remedies Private Limited?

The primary industry of Maple Cross Remedies Private Limited is Trade.

Is Maple Cross Remedies Private Limited a listed company?

Maple Cross Remedies Private Limited is unlisted.

What is the capital structure of Maple Cross Remedies Private Limited?

The authorized capital of Maple Cross Remedies Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Maple Cross Remedies Private Limited?

The compliance status of Maple Cross Remedies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available